Reports for LORAZEPAM

Ingredient

LORAZEPAM

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LORAZEPAM 0.5MG TABLET Resolved 2022-06-30 2023-04-28 163918
TEVA-LORAZEPAM 2MG TABLET Resolved 2022-06-30 2023-06-09 163915
TEVA-LORAZEPAM 1MG TABLET Resolved 2022-06-30 2023-04-28 163912
APO-LORAZEPAM 2MG TABLET Resolved 2022-04-01 2022-05-13 157698
LORAZEPAM INJECTION USP 4MG SOLUTION LIQUID Resolved 2022-03-14 2023-07-28 156638
LORAZEPAM INJECTION USP 4MG SOLUTION LIQUID Resolved 2022-01-12 2022-01-18 152589
LORAZEPAM INJECTION USP 4MG SOLUTION LIQUID Resolved 2021-12-20 2021-12-30 151603
APO-LORAZEPAM 2MG TABLET Resolved 2021-12-01 2021-12-20 150252
ATIVAN 2MG TABLET Resolved 2021-11-30 2022-02-01 150219
LORAZEPAM SUBLINGUAL 1MG TABLET Resolved 2021-09-09 2021-09-30 145410

Showing 11 to 20 of 79

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
LORAZEPAM 2.0MG TABLET Discontinued 2021-12-16 2021-12-17 151293
LORAZEPAM 2.0MG TABLET Discontinued 2021-08-12 2022-02-06 144029
LORAZEPAM 1.0MG TABLET Discontinued 2021-05-17 2021-11-16 139511
PMS-LORAZEPAM 1MG TABLET Discontinued 2020-06-15 2021-10-27 117720
PMS-LORAZEPAM 0.5MG TABLET Discontinued 2020-06-15 2021-10-27 117717
LORAZEPAM Discontinued 2020-02-27 2020-02-27 107347
LORAZEPAM INJECTION USP 2MG SOLUTION Discontinued 2020-02-14 2020-03-12 106265
APO-LORAZEPAM 1MG TABLET Discontinued 2018-09-07 2018-10-05 60594
APO-LORAZEPAM 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
LORAZEPAM 2MG TABLET Discontinued 2017-06-06 2017-06-07 11986

Showing 1 to 10 of 13